miR-140 inhibits osteosarcoma progression by impairing USP22-mediated LSD1 stabilization and promoting p21 expression
Wei Liu1, Dunwei Wang2, Lidi Liu1
1Department of Spine Surgery, The First Hospital of Jilin University, Changchun 130021, P.R. China.
Abstract:
Osteosarcoma is a bone tumor frequently diagnosed in children and young adults. Despite advances in chemotherapy and surgical resection, tumors metastasize in 30% of osteosarcoma patients. In addition, side effects caused by chemotherapeutic drugs, as well as the development of chemoresistance, highlight the need to identify the molecular mechanisms involved in the pathogenesis of osteosarcoma. We compared 65 osteosarcoma samples to their adjacent normal tissues, as well as commercially obtained osteosarcoma cell lines with normal osteoblast cell lines, and identified a role for the microRNA (miR)-140/ubiquitin-specific protease 22 (USP22)/lysine-specific demethylase 1 (LSD1)/p21 axis in the development of osteosarcoma. Osteosarcoma tissues and cells exhibited poor miR-140 and p21 expression, whereas the expression of USP22 and LSD1 was increased. Overexpression of miR-140 inhibited cell proliferation, migration, and invasion and promoted cell apoptosis by directly targeting USP22, resulting in its decreased expression. Overexpression of USP22 reversed the effects of miR-140 overexpression in osteosarcoma cells. Overexpression of miR-140 or USP22 knockdown led to the ubiquitination and degradation of LSD1. miR-140 overexpression also suppressed tumorigenesis in vivo. This study revealed a role for miR-140 in the restriction of osteosarcoma development and identified miR-140 as a potential target for therapeutic intervention.
Insights
MicroRNA-140 acts as a tumor suppressor in osteosarcoma, inhibiting cancer growth and spread. Targeting this microRNA may offer new therapeutic strategies for this bone cancer.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- Osteosarcoma is a prevalent bone cancer in young individuals.
- Metastasis and chemoresistance remain significant challenges in osteosarcoma treatment.
- Understanding molecular pathogenesis is crucial for developing novel therapies.
Purpose of the Study:
- To investigate the molecular mechanisms underlying osteosarcoma development.
- To identify key molecular players in osteosarcoma progression.
- To explore the therapeutic potential of microRNA-140 (miR-140) in osteosarcoma.
Main Methods:
- Comparative analysis of 65 osteosarcoma tissues and adjacent normal tissues.
- Comparison of osteosarcoma cell lines with normal osteoblast cell lines.
- Investigation of the miR-140/ubiquitin-specific protease 22 (USP22)/lysine-specific demethylase 1 (LSD1)/p21 axis.
- Functional assays including cell proliferation, migration, invasion, apoptosis, and in vivo tumorigenesis studies.
Main Results:
- Osteosarcoma tissues and cells showed decreased miR-140 and p21 expression, with increased USP22 and LSD1.
- miR-140 overexpression suppressed osteosarcoma cell proliferation, migration, and invasion, while promoting apoptosis by targeting USP22.
- USP22 overexpression counteracted the effects of miR-140.
- miR-140 overexpression or USP22 knockdown induced ubiquitination and degradation of LSD1.
- In vivo studies confirmed miR-140's tumor-suppressive role.
Conclusions:
- The miR-140/USP22/LSD1/p21 axis is implicated in osteosarcoma pathogenesis.
- miR-140 functions as a tumor suppressor in osteosarcoma.
- miR-140 represents a promising therapeutic target for osteosarcoma treatment.
More Related Videos
Related Concept Videos
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Abnormal Proliferation
MicroRNAs
MicroRNAs


